By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Protein Sciences Corporation 

1000 Research Parkway

Meriden  Connecticut  06450  U.S.A.
Phone: 203-686-0800 Fax: 203-686-0268



Company News
Protein Sciences Corporation Release: Flublok Influenza Vaccine Approved In Mexico 11/18/2015 9:23:36 AM
Protein Sciences Corporation Awarded A Small Business Innovation Research Grant For The Development Of A Novel Adenovirus Vaccine 11/12/2015 8:57:45 AM
Protein Sciences Corporation President And CEO Manon Cox Elected As 2015 Fellow Of The International Society For Vaccines 10/30/2015 6:26:43 AM
Protein Sciences Corporation Release: Flublok Influenza Vaccine Is Now Nationwide 9/23/2015 11:00:36 AM
Protein Sciences Corporation Receives Approval from FDA For 2015/16 Formulation Of Flublok Influenza Vaccine 7/8/2015 10:04:50 AM
Protein Sciences Corporation Release: New Clinical Study of Flublok Influenza Vaccine Shows That Groundbreaking Flublok Is More Effective Than The Traditional Flu Shot 6/25/2015 11:21:09 AM
In Rare Move, FDA Grants Exclusivity To Protein Sciences Corporation' Flublok For 12 Years 6/3/2015 10:07:39 AM
Protein Sciences Corporation New York Facility Receives FDA Licensure To Manufacture Flublok 5/13/2015 3:37:39 PM
Protein Sciences Corporation Release: Clinical Efficacy Study Of Flublok® Quadrivalent Compares Flublok To A Traditional Egg-Based Flu Vaccine 1/29/2015 8:31:17 AM
Frost & Sullivan New Product Innovation Award Conferred On Protein Sciences Corporation For FlublokĀ® Influenza Vaccine 12/30/2014 7:38:41 AM